In pancreatic ductal adenocarcinoma (PDAC), RNA sequencing and multiplex immunofluorescence have shown that early-stage liver metastatic patients (T1M1) exhibit increased expression of mixed lineage kinase domain-like pseudokinase (MLKL). This evidence concerns the gene MLKL and pancreatic ductal adenocarcinoma.